Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy.

Wang GS, Bourne DWA, Klawitter J, Sempio C, Chapman K, Knupp K, Wempe MF, Borgelt L, Christians U, Heard K, Bajaj L.

Clin Toxicol (Phila). 2020 Feb;58(2):124-128. doi: 10.1080/15563650.2019.1616093. Epub 2019 May 21.

PMID:
31111749
2.

Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats.

Patil MA, Matter BA, Raol YH, Bourne DWA, Kelley RA, Kompella UB.

Pharmaceutics. 2018 Dec 16;10(4). pii: E281. doi: 10.3390/pharmaceutics10040281.

3.

Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes.

Smith WJ, Wang G, Gaikwad H, Vu VP, Groman E, Bourne DWA, Simberg D.

ACS Nano. 2018 Dec 26;12(12):12523-12532. doi: 10.1021/acsnano.8b07003. Epub 2018 Dec 5.

4.

Morphine Pharmacokinetics in Children With Down Syndrome Following Cardiac Surgery.

Goot BH, Kaufman J, Pan Z, Bourne DWA, Hickey F, Twite M, Galinkin J, Christians U, Zuk J, da Cruz EM.

Pediatr Crit Care Med. 2018 May;19(5):459-467. doi: 10.1097/PCC.0000000000001537.

PMID:
29547456
5.

Anatomical and physiological basis for the allometric scaling of cisplatin clearance in dogs.

Achanta S, Sewell A, Ritchey JW, Broaddus K, Bourne DW, Clarke CR, Maxwell LK.

J Vet Pharmacol Ther. 2016 Jun;39(3):224-36. doi: 10.1111/jvp.12266. Epub 2015 Oct 6.

PMID:
26440900
6.

Effect of cooling rates and temperatures on quality and safety of quahog clams (Mercenaria mercenaria).

Granata LA, Bourne DW, Flick GJ Jr, Peirson M, Riley T, Croonenberghs RE, Kensler J.

J Food Prot. 2014 May;77(5):843-8. doi: 10.4315/0362-028X.JFP-13-413.

PMID:
24780343
7.

Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak RS 3rd, Larabee C, Iqbal H, Floyd RA, Bourne DW, Abdullah O, Hsu EW, Jensen RL.

Neuro Oncol. 2013 Mar;15(3):330-40. doi: 10.1093/neuonc/nos337. Epub 2013 Jan 17.

8.

Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.

Aquilante CL, Kosmiski LA, Bourne DW, Bushman LR, Daily EB, Hammond KP, Hopley CW, Kadam RS, Kanack AT, Kompella UB, Le M, Predhomme JA, Rower JE, Sidhom MS.

Br J Clin Pharmacol. 2013 Jan;75(1):217-26. doi: 10.1111/j.1365-2125.2012.04343.x.

9.

Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.

Kadam RS, Bourne DW, Kompella UB.

Drug Metab Dispos. 2012 Jul;40(7):1380-8. doi: 10.1124/dmd.112.044925. Epub 2012 Apr 12.

10.

Gastrointestinal absorption of phenytoin from an oil-in-water microemulsion.

Kwon KI, Bourne DW.

Arch Pharm Res. 1997 Oct;20(5):480-5. doi: 10.1007/BF02973944.

PMID:
18982494
11.

Pharmacokinetics of valacyclovir in the adult horse.

Maxwell LK, Bentz BG, Bourne DW, Erkert RS.

J Vet Pharmacol Ther. 2008 Aug;31(4):312-20. doi: 10.1111/j.1365-2885.2008.00957.x.

PMID:
18638291
12.

A self-paced course in pharmaceutical mathematics using web-based databases.

Bourne DW, Davison AM.

Am J Pharm Educ. 2006 Oct 15;70(5):116.

13.

Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus.

Dimas VV, Taylor MD, Cunnyngham CB, Overholt ED, Bourne DW, Stanely JR 3rd, Sheikh A, Wolf R, Valentine B, Ward KE.

Pediatr Cardiol. 2005 Nov-Dec;26(6):815-20. Erratum in: Pediatr Cardiol. 2007 Jan-Feb;28(1):76. Dimasc, V V [corrected to Dimas, V V].

PMID:
16132275
14.
15.

Bioavailability of intranasal promethazine dosage forms in dogs.

Ramanathan R, Geary RS, Bourne DW, Putcha L.

Pharmacol Res. 1998 Jul;38(1):35-9.

PMID:
9697152
16.

Using the Internet as a pharmacokinetic resource.

Bourne DW.

Clin Pharmacokinet. 1997 Sep;33(3):153-60.

PMID:
9314609
17.

Disposition of aerosolized liposomal amphotericin B.

Lambros MP, Bourne DW, Abbas SA, Johnson DL.

J Pharm Sci. 1997 Sep;86(9):1066-9.

PMID:
9294824
18.

New high-performance liquid chromatographic method for amphotericin B analysis using an internal standard.

Lambros MP, Abbas SA, Bourne DW.

J Chromatogr B Biomed Appl. 1996 Oct 11;685(1):135-40.

PMID:
9026302
19.

Bioavailability of intranasal scopolamine in normal subjects.

Putcha L, Tietze KJ, Bourne DW, Parise CM, Hunter RP, CintrĂ³n NM.

J Pharm Sci. 1996 Aug;85(8):899-902.

PMID:
8863287
20.

Metabolism and metabolite pharmacokinetics of BRB-I-28, a class Ib antiarrhythmic agent.

Chen CL, Sangiah S, Bourne DW, Roder JD, Chen H, Alavi FK, Clarke CR, Garrison GL, Berlin KD, Couch KM, et al.

Eur J Drug Metab Pharmacokinet. 1995 Apr-Jun;20(2):151-61.

PMID:
8582441
21.
22.

Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients.

Smith CL, Hampton EM, Pederson JA, Pennington LR, Bourne DW.

Pharmacotherapy. 1994 Jul-Aug;14(4):471-81.

PMID:
7937285
23.

Application of physiologically based pharmacokinetic models for assessing drug disposition in space.

Srinivasan RS, Bourne DW, Putcha L.

J Clin Pharmacol. 1994 Jun;34(6):692-8. Review.

PMID:
8083402
24.

Pharmacokinetic evaluation of a new oral cyclosporine formulation.

Whipple JK, Lewis KS, Weitman SD, Ausman RK, Bourne DW, Andrews W, Adams MB, Sasse EA, Quebbeman EJ.

Pharmacotherapy. 1994 Jan-Feb;14(1):105-10.

PMID:
8159594
25.
26.

Physiological modeling of disposition of potential tumor-imaging radiopharmaceuticals in tumor-bearing mice.

Bourne DW, Jacobs JJ, Awaluddin A, Maddalena DJ, Wilson JG, Boyd RE.

J Pharm Sci. 1992 May;81(5):408-12.

PMID:
1403669
27.

Interaction of cyclosporine and probucol in heart transplant patients.

Sundararajan V, Cooper DK, Muchmore J, Manion CV, Liguori C, Zuhdi N, Novitzky D, Chen PN, Bourne DW, Corder CN.

Transplant Proc. 1991 Jun;23(3):2028-32. No abstract available.

PMID:
2063476
28.
29.

Biological evaluation of 99mTc labelled cis-platinum containing benzyliminodiacetic acids as potential tumour imaging agents.

Jacobs JJ, Maddalena DJ, Wilson JG, Awaluddin A, King-Christopher J, Bourne DW.

Int J Rad Appl Instrum B. 1990;17(4):397-400.

PMID:
2143755
30.

Subcutaneously implanted tissue chambers--a pharmacokinetic study.

Clarke CR, Short CR, Bourne DW, Usenik EA.

J Vet Pharmacol Ther. 1989 Sep;12(3):312-21.

PMID:
2810481
31.
32.

BOOMER, a simulation and modeling program for pharmacokinetic and pharmacodynamic data analysis.

Bourne DW.

Comput Methods Programs Biomed. 1989 Jul;29(3):191-5.

PMID:
2776455
33.
34.

Extension of the serum digoxin concentration--response relationship to patient management.

Kolibash AJ Jr, Lewis RP, Bourne DW, Kramer WG, Reuning RH.

J Clin Pharmacol. 1989 Apr;29(4):300-6.

PMID:
2723118
35.
36.

Synthesis and characterization of potential tumor scintigraphic agents.

Awaluddin AB, Jacobs JJ, Bourne DW, Maddalena DJ, Wilson JG, Boyd RE.

Int J Rad Appl Instrum A. 1987;38(8):671-4.

PMID:
2822626
37.

MULTI-FORTE, a microcomputer program for modelling and simulation of pharmacokinetic data.

Bourne DW.

Comput Methods Programs Biomed. 1986 Dec;23(3):277-81.

PMID:
3816175
38.

Pharmacokinetic evaluation of a slow-release cefotaxime suspension in the dog and in sheep.

Guerrini VH, English PB, Filippich LJ, Schneider J, Bourne DW.

Am J Vet Res. 1986 Sep;47(9):2057-61.

PMID:
3767112
39.

Effect of caffeine on ceftriaxone disposition and plasma protein binding in the rat.

Kwon KI, Bourne DW.

J Pharmacokinet Biopharm. 1986 Aug;14(4):397-408. Erratum in: J Pharmacokinet Biopharm 1987 Jun;15(3):345.

PMID:
3689487
40.

Pharmacokinetics of cefotaxime in the dog.

Guerrini VH, English PB, Filippich LJ, Schneider J, Bourne DW.

Vet Rec. 1986 Jul 26;119(4):81-3.

PMID:
3750783
41.

Parenteral nutrition.

Young GP, Thomas RJ, Bourne DW, Russell DM.

Med J Aust. 1985 Dec 9-23;143(12-13):597-601. No abstract available.

PMID:
3938521
42.

Effect of caffeine on the plasma protein binding and the disposition of ceftriaxone.

Kwon KI, Bourne DW, Ho PC.

J Pharm Pharmacol. 1985 Nov;37(11):836-9.

PMID:
2867172
43.

Determination of gallium concentration in "blood-free" tissues using a radiolabeled blood marker.

Triplett JW, Hayden TL, McWhorter LK, Gautam SR, Kim EE, Bourne DW.

J Pharm Sci. 1985 Sep;74(9):1007-9.

PMID:
4067841
44.

Pharmacokinetics of probenecid in sheep.

Guerrini VH, Filippich LJ, English PB, Schneider J, Cao GR, Bourne DW.

J Vet Pharmacol Ther. 1985 Jun;8(2):128-35.

PMID:
4020944
45.

Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.

Guerrini VH, Filippich LJ, Cao GR, English PB, Bourne DW.

J Vet Pharmacol Ther. 1985 Jun;8(2):120-7.

PMID:
4020943
46.

The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.

Ho PC, Triggs EJ, Bourne DW, Heazlewood VJ.

Br J Clin Pharmacol. 1985 May;19(5):675-84.

47.

Effect of probenecid on the pharmacokinetics of cefotaxime in sheep.

Guerrini VH, Filippich LJ, English PB, Cao GR, Bourne DW.

J Vet Pharmacol Ther. 1985 Mar;8(1):38-46.

PMID:
3989899
48.

Pharmacokinetics of cefotaxime and probenecid in sheep with normal and reduced renal function.

Guerrini VH, Filippich LJ, English PB, Cao GR, Bourne DW.

J Vet Pharmacol Ther. 1984 Dec;7(4):283-91.

PMID:
6096576
49.

Physiological model for distribution of sulfathiazole in swine.

Duddy J, Hayden TL, Bourne DW, Fiske WD, Benedek IH, Stanley D, Gonzalez A, Heierman W.

J Pharm Sci. 1984 Nov;73(11):1525-8.

PMID:
6520750
50.

Determination of oxycodone in human plasma by high-performance liquid chromatography with electrochemical detection.

Schneider JJ, Triggs EJ, Bourne DW, Stephens ID, Haviland AM.

J Chromatogr. 1984 Jun 8;308:359-62. No abstract available.

PMID:
6746828

Supplemental Content

Loading ...
Support Center